Lercanidipine: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
No edit summary |
||
| Line 48: | Line 48: | ||
* {{DiseasesDB|31597}} | * {{DiseasesDB|31597}} | ||
[[Category: Calcium channel blockers]] | |||
[[Category: | |||
[[Category: Selective calcium channel blockers with mainly vascular effects]][[Category: Dihydropyridine derivatives]][[Category: Cardiovascular Drugs]] | |||
[[Category:Pyridines]] | [[Category:Pyridines]] | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 15:06, 23 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C36H41N3O6 |
| Molar mass | 611.727 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Lercanidipine is a calcium channel blocker of the dihydropyridine class.
It is sold under various commercial names including Zanidip.
Further reading
- Lin T, Voon W, Yen H, Huang C, Su H, Lai W, Sheu S (2006). "Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters". Kaohsiung J Med Sci. 22 (4): 177–83. PMID 16679299.
- Martinez M, Lopes L, Coelho E, Nobre F, Rocha J, Gerlach R, Tanus-Santos J (2006). "Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension". J Cardiovasc Pharmacol. 47 (1): 117–22. PMID 16424795.
- Agrawal R, Marx A, Haller H (2006). "Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension". J Hypertens. 24 (1): 185–92. PMID 16331117.
External links
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- CS1 maint: Multiple names: authors list
- Calcium channel blockers
- Selective calcium channel blockers with mainly vascular effects
- Dihydropyridine derivatives
- Cardiovascular Drugs
- Pyridines
- Drugs